Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Collagen/bone growth factor - Millenium Biologix Corporation

Drug Profile

Collagen/bone growth factor - Millenium Biologix Corporation

Alternative Names: BCSP; BCSS; Bone and Cartilage Stimulating Peptides - Millenium Biologix; Bone cell stimulating substances; Primacoll

Latest Information Update: 02 Jun 2010

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Millenium Biologix Corporation
  • Class Biopolymers
  • Mechanism of Action Collagen stimulants; Intercellular signalling peptide and protein stimulants; Osteogenesis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Bone disorders

Most Recent Events

  • 16 Nov 2005 Clinical trials in Bone regeneration in Canada (Intralesional)
  • 16 Nov 2005 Millenium Biologix Corporation voluntarily withdrew its submission to Health Canada for Primacoll™ for bone regeneration during the second quarter of 2005
  • 21 Sep 2005 Launched for Bone regeneration in Europe (Intralesional) - first global launch
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top